HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Etiology-specific endothelin-1 clearance in human precapillary pulmonary hypertension.

AbstractSTUDY OBJECTIVES:
Endothelin (ET)-1 is a mediator of vascular remodeling seen in human pulmonary hypertension (PH), and it is normally cleared via endothelial ET-B receptors. Increased levels of ET-1 are found in precapillary PH, partly from increased synthesis. We hypothesized that the endothelial dysfunction and vascular remodeling seen in human precapillary PH would also reduce ET-1 clearance.
DESIGN AND SETTING:
Case series from a single institutional PH center.
PATIENTS:
Thirty-four patients with pulmonary arterial hypertension (PAH; idiopathic [IPAH], n = 19; connective tissue disease [CTD], n = 15) and 11 patients with chronic thromboembolic PH were studied.
MEASUREMENTS AND RESULTS:
Using indicator dilution methods, the first-pass extraction of radiolabeled ET-1 through the pulmonary circulation, and permeability surface (PS) area, an index of functional microvascular surface available for ET-1 clearance, were determined. Mean extraction for IPAH and thromboembolic PH groups was normal, but it was reduced in PAH from CTD; 69% of all patients studied had normal extraction. The mean PS product was reduced significantly for all three etiologies as compared to normal, but 58% of IPAH patients and 40% of CTD-related PAH patients had normal PS products.
CONCLUSIONS:
Receptor-mediated ET-1 extraction and functional vascular surface area for clearance vary between etiologies of PAH. However, contrary to our hypothesis, endothelial ET-B receptor-mediated extraction is preserved in many patients. The scientifically significant finding of our study is that high ET-1 levels seen in patients with PAH must be predominantly due to excess synthesis rather than reduced clearance. The finding that endothelial ET-B receptors are still present and functional in PAH may also be of relevance to the choice of selective vs nonselective ET receptor antagonists.
AuthorsDavid Langleben, Jocelyn Dupuis, Isaac Langleben, Andrew M Hirsch, Murray Baron, Jean-Luc Senécal, Michele Giovinazzo
JournalChest (Chest) Vol. 129 Issue 3 Pg. 689-95 (Mar 2006) ISSN: 0012-3692 [Print] United States
PMID16537869 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Cyclohexanones
  • Endothelin-1
  • Glucosides
  • precarthamin
Topics
  • Cyclohexanones
  • Endothelin-1 (metabolism)
  • Endothelium, Vascular (physiopathology)
  • Female
  • Glucosides
  • Humans
  • Hypertension, Pulmonary (etiology, metabolism)
  • Indicator Dilution Techniques
  • Male
  • Microcirculation (physiology)
  • Pulmonary Diffusing Capacity
  • Thermodilution

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: